SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the June 2024 quarter moved down to Rs. 16312.00 millions as compared to Rs. 17396.00 millions during the year-ago period.A slender decline of -22.62% was recorded to Rs. 2542.00  millions from Rs. 3285.00 millions in the corresponding previous quarter.Operating profit for the quarter ended June 2024 decreased to 3415.00 millions as compared to 4453.00 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 16312.00 17396.00 -6.23 16312.00 17396.00 -6.23 51032.00 51397.00 -0.71
Other Income 275.00 207.00 32.85 275.00 207.00 32.85 810.00 639.00 26.76
PBIDT 3415.00 4453.00 -23.31 3415.00 4453.00 -23.31 10350.00 9881.00 4.75
Interest 42.00 79.00 -46.84 42.00 79.00 -46.84 196.00 223.00 -12.11
PBDT 3373.00 4374.00 -22.89 3373.00 4374.00 -22.89 10154.00 10696.00 -5.07
Depreciation 215.00 313.00 -31.31 215.00 313.00 -31.31 740.00 795.00 -6.92
PBT 3158.00 4061.00 -22.24 3158.00 4061.00 -22.24 9414.00 9901.00 -4.92
TAX 616.00 776.00 -20.62 616.00 776.00 -20.62 2009.00 2319.00 -13.37
Deferred Tax 12.00 22.00 -45.45 12.00 22.00 -45.45 25.00 106.00 -76.42
PAT 2542.00 3285.00 -22.62 2542.00 3285.00 -22.62 7405.00 7582.00 -2.33
Equity 449.00 449.00 0.00 449.00 449.00 0.00 449.00 449.00 0.00
PBIDTM(%) 20.94 25.60 -18.21 20.94 25.60 -18.21 20.28 19.22 5.50

Bayer CropScience Share Price

4933.30 -64.65 (-1.29%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 659.60
PI Industries 3114.60
Bayer CropScience 4933.30
Sharda Cropchem 1100.65
Sumitomo Chemical 424.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×